Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Drug Resistance

Free Subscription 09.02.2026 11 Antimicrob Agents Chemother 2 Clin Infect Dis 1 Int J Antimicrob Agents 6 J Antimicrob Chemother 2 J Infect Chemother 1 PLoS Biol 1 PLoS Comput Biol 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. COLLINGS H, Stone M, Chrysostomou M, Hirst A, et al
   A systematic literature review and (network) meta-analysis of the effectiveness of ceftolozane/tazobactam versus aminoglycosides/polymyxins and ceftazidime/avibactam for treating adult patients with multidrug-resistant Pseudomonas aeruginosa infection
   Antimicrob Agents Chemother. 2026;70:e0073525.
   PubMed         Abstract available
   
   
2. ANEKE CI, Shahegh SS, Freeman AF, Zerbe C, et al
   Beyond Fumigatus: a molecular portrait of clinical Aspergillus diversity, pathogenicity, and antifungal resistance.
   Antimicrob Agents Chemother. 2026 Jan 13:e0118425. doi: 10.1128/aac.01184.
   PubMed         Abstract available
   
   
3. MOHAMMAD S, Al Namer Y, Rahimeh W, Albalas M, et al
   Effectiveness and safety of meropenem-vaborbactam versus ceftazidime-avibactam in multidrug-resistant Gram-negative infections: a systematic review and meta-analysis with trial sequential analysis.
   Antimicrob Agents Chemother. 2026;70:e0154625.
   PubMed         Abstract available
   
   
4. OMACHI R, Imai K, Sato A, Tanaka M, et al
   Spread of dual-class drug-resistant Mycoplasma genitalium in Tokyo, Japan, 2023-2025.
   Antimicrob Agents Chemother. 2026;70:e0136725.
   PubMed         Abstract available
   
   
5. FAN M, Zhang Z, Liu X, Deng L, et al
   Phylogenetic diversification and fitness trade-offs of TetA variants in mediating eravacycline resistance in Klebsiella pneumoniae.
   Antimicrob Agents Chemother. 2026;70:e0067125.
   PubMed         Abstract available
   
   
6. FINGLETON C, Zeden MS, Bueno E, Cava F, et al
   Mutation of lipoprotein processing pathway gene lspA or inhibition of LspA activity by globomycin increases MRSA resistance to beta-lactam antibiotics.
   Antimicrob Agents Chemother. 2026;70:e0127625.
   PubMed         Abstract available
   
   
7. LIU Y, Cui P, Sun J, Ru S, et al
   A short antimicrobial peptides family demonstrates efficacy to infection via a multimodal mechanism of action.
   Antimicrob Agents Chemother. 2026;70:e0134325.
   PubMed         Abstract available
   
   
8. TIREAU B, Hamane S, Weber S, Benderdouche M, et al
   Comparison of gradient concentration strip and EUCAST methods for itraconazole and posaconazole MICs in Trichophyton indotineae.
   Antimicrob Agents Chemother. 2026;70:e0129325.
   PubMed         Abstract available
   
   
9. BAEZ-BARROSO G-A, Rodriguez-Coello A, Vazquez-Ucha JC, Lopez-Arguello S, et al
   Antibacterial activity of enmetazobactam against Acinetobacter spp.: a molecular dissection of mechanism of action and resistance determinants.
   Antimicrob Agents Chemother. 2026;70:e0120625.
   PubMed         Abstract available
   
   
10. LEONARD VHJ, Vidales DB, Taft BR, Hesse MJ, et al
    Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerization.
    Antimicrob Agents Chemother. 2025 Dec 19:e0114925. doi: 10.1128/aac.01149.
    PubMed         Abstract available
    
    
11. ALHOTHALI MT, Seemann T, Andersson P, Sherry N, et al
    Rising burden of enterococcal bacteremia in Victoria, Australia: population-based incidence and antimicrobial resistance trends from three decades of surveillance.
    Antimicrob Agents Chemother. 2026 Feb 4:e0152625. doi: 10.1128/aac.01526.
    PubMed         Abstract available
    
    

    
    Clin Infect Dis

12. LU X, Jiang Y, Zhang R, Zhang Y, et al
    Epidemiologic and Bacterial Factors Facilitating Long-Term Transmission of Multidrug-Resistant Tuberculosis in Shanghai, China.
    Clin Infect Dis. 2025 Jun 18:ciaf313. doi: 10.1093.
    PubMed         Abstract available
    
    
13. OLDENBURG CE, Coulibaly B, Sie A, Ouattara M, et al
    Macrolide and non-macrolide resistance after 36 months of mass azithromycin distribution in Burkina Faso: A cluster randomized trial.
    Clin Infect Dis. 2026 Jan 31:ciag051. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Int J Antimicrob Agents

14. DONG R, Wang Y, Song L, Wang J, et al
    Rapid Detection of NDM-Producing Carbapenem-Resistant Escherichia coli Using MALDI-TOF MS Combined with Machine Learning Techniques.
    Int J Antimicrob Agents. 2026 Jan 29:107726.
    PubMed         Abstract available
    
    

    
    J Antimicrob Chemother

15. KARAKONSTANTIS S, Tziolos RN, Paneta M, Kritsotakis EI, et al
    Global and regional prevalence of metallo-beta-lactamases in carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2026;81:dkag037.
    PubMed         Abstract available
    
    
16. THORINGTON R, Barairo N, Peterson SW, Lourenco L, et al
    Summary of ceftriaxone-resistant Neisseria gonorrhoeae in Canada, 2017-24.
    J Antimicrob Chemother. 2026;81:dkag007.
    PubMed         Abstract available
    
    
17. VAN OSCH JAT, Voermans JJC, Ouzerne H, Cromme ABH, et al
    Cooperation between HIV-1 integrase natural polymorphism K156N and 3'PPT mutations in dolutegravir monotherapy failure.
    J Antimicrob Chemother. 2026;81:dkag033.
    PubMed         Abstract available
    
    
18. YAMANO Y, Takemura M, Longshaw C, DeJonge BLM, et al
    Understanding mechanisms of reduced cefiderocol susceptibility in pvdS and fecI mutants of Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2026;81:dkag004.
    PubMed         Abstract available
    
    
19. 
    Correction to: Bayesian estimation of the prevalence of antimicrobial resistance: a mathematical modelling study.
    J Antimicrob Chemother. 2026;81:dkaf494.
    PubMed        
    
    
20. LI Y, Dong H, Liu X, Shen Y, et al
    IS26-mediated chromosomal integration of virulence plasmid fragments in ST2237 carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2026;81:dkag018.
    PubMed        
    
    

    
    J Infect Chemother

21. NAKAMURA A, Nakamura T, Niki M, Kuchibiro T, et al
    Comprehensive genomic analysis of ESBL- and carbapenemase-producing Escherichia coli ST131 in Japan: Genetic characteristics of pandemic clade C.
    J Infect Chemother. 2026;32:102915.
    PubMed         Abstract available
    
    
22. OKANDA T, Nakajima N, Koshikawa T, Oyanagi T, et al
    Evaluation of Japan-specific cefiderocol susceptibility testing methods in multidrug-resistant gram-negative isolates from Japan and Bangladesh.
    J Infect Chemother. 2026;32:102903.
    PubMed         Abstract available
    
    

    
    PLoS Biol

23. SON YE, Perez-Arques C, Heitman J
    Epimutations driven by RNAi or heterochromatin evoke transient antimicrobial drug resistance in pathogenic Mucor fungi.
    PLoS Biol. 2026;24:e3003598.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

24. AGGARWAL M, Periwal V
    Forecasting drug resistant HIV protease evolution.
    PLoS Comput Biol. 2026;22:e1013913.
    PubMed         Abstract available
    
    

    
    PLoS One

25. VON WINTERSDORFF CJH, Roelofsen M, Versteegh L, Benyahya Y, et al
    Vancomycin variable Enterococci in the Netherlands (2018-2023) and the mechanism of resistance induction.
    PLoS One. 2026;21:e0342092.
    PubMed         Abstract available
    
    
26. PRAPTI BBR, Ahmmed MT, Rahman A, Chouhan CS, et al
    First report of extended-spectrum beta lactamase (ESBL) and carbapenemase-producing MDR Klebsiella pneumoniae from Fuchka.
    PLoS One. 2026;21:e0341583.
    PubMed         Abstract available
    
    
27. AKTAR MT, Prapti BBR, Rahman A, Siddyqua MA, et al
    Virulent MDR Edwardsiella tarda from stinging catfish (Heteropneustes fossilis).
    PLoS One. 2026;21:e0340061.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum